TRATAMIENTO DE LA HEMORRAGIA AGUDA VARICEAL EN PACIENTE CON CIRROSIS HEPÁTICA

Calixto Duarte Chang

Submitted October 30, 2024

Published 2026-02-02

Artículos de Investigación

Vol. 34 No. 2 (2021): Revista Médico Científica

TREATMENT OF ACUTE VARICEAL HEMORRHAGE IN PATIENT WITH LIVER CIRRHOSIS

Calixto Duarte Chang ⁺⁻

PDF (Español (España))

Citación:

DOI: ND

Published: 2026-02-02

How to Cite

1.

Duarte Chang C. TREATMENT OF ACUTE VARICEAL HEMORRHAGE IN PATIENT WITH LIVER CIRRHOSIS. rmc [Internet]. 2026 Feb. 2 [cited 2026 Oct. 18];34(2):1-4. Available from: https://revistas.up.ac.pa/index.php/revistamedicocientifica/article/view/6177

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Abstract

ABSTRACT:

Upper gastrointestinal bleeding due to esophageal varices rupture is a major complication in patients with portal hypertension and the most frequent cause of death in patients with liver cirrhosis. Treatment of acute bleeding from esophageal varices includes pharmacological and endoscopic measures.

Among endoscopic management options, esophageal variceal ligation with elastic bands is the treatment of choice, offering good outcomes and lower complication rates compared to other methods, such as sclerotherapy.

We present the case of a 61-year-old man admitted for massive hematemesis secondary to esophageal varices rupture, who evolved favorably after medical and endoscopic management

Downloads

Download data is not yet available.

References

BIBLIOGRAFÍA
D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post- therapeutic outcome and prognostic
indicators. Hepatology 2003;38:599–612.
Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish
population-based cohort study. Hepatology 2010;51:1675–1682.
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823–832:
Villanueva C, Escorsell A. Optimizing general management of acute variceal bleeding in cirrhosis. Curr Hepatol Rep 2014;13:198–207.
De Franchis RBaveno VI faculty. Expanding consensus in portal hypertension: report of the BAVENO VI Consensus
Workshop: Strati- fying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743–752.
Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350: 1495–1499.
Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–868
Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for
acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11–21.
Villanueva C, Escorsell A. Optimizing general management of acute variceal bleeding in cirrhosis. Curr Hepatol Rep 2014;13:198–207.
D’Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014;39:1180–11.

Keywords

PDF (Español (España))

Resumen visto - 215 veces
PDF (Español (España)) descargado - 3

Licencia

Content Top

[1] BIBLIOGRAFÍA

[2] D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post- therapeutic outcome and prognostic

[3] indicators. Hepatology 2003;38:599–612.

[4] Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish

[5] population-based cohort study. Hepatology 2010;51:1675–1682.

[6] Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823–832:

[7] Villanueva C, Escorsell A. Optimizing general management of acute variceal bleeding in cirrhosis. Curr Hepatol Rep 2014;13:198–207.

[8] De Franchis RBaveno VI faculty. Expanding consensus in portal hypertension: report of the BAVENO VI Consensus

[9] Workshop: Strati- fying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743–752.

[10] Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997;350: 1495–1499.

[11] Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–868

[12] Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for

[13] acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11–21.

[14] Villanueva C, Escorsell A. Optimizing general management of acute variceal bleeding in cirrhosis. Curr Hepatol Rep 2014;13:198–207.

[15] D’Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014;39:1180–11.

Cover image